{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:55:32Z","timestamp":1790596532588,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04795-1","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:02:07Z","timestamp":1790593327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 vaccine-associated autoimmune thyroid eye disease: Graves\u2019 orbitopathy"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3096-6100","authenticated-orcid":false,"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rida","family":"Afnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"8","key":"4795_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu, P. Niu, F. Zhan, X. Ma, D. Wang, W. Xu, G. Wu, G.F. Gao, W. Tan, China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl. J. Med. 382(8), 727\u2013733 (2020). https:\/\/doi.org\/10.1056\/NEJMoa2001017","journal-title":"N Engl. J. Med."},{"key":"4795_CR2","unstructured":"The World Health Organization (WHO) https:\/\/www.who.int."},{"key":"4795_CR3","doi-asserted-by":"publisher","unstructured":"Li, M. Y., Li, L., Zhang, Y., & Wang, X. S. (2020). Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, 9, 45. https:\/\/doi.org\/10.1186\/s40249-020-00662-x","DOI":"10.1186\/s40249-020-00662-x"},{"issue":"3","key":"4795_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s12020-023-03415-6","volume":"81","author":"AK Murugan","year":"2023","unstructured":"A.K. Murugan, A.S. Alzahrani, Potential impacts of SARS-CoV-2 on parathyroid: current advances and trends. Endocrine. 81(3), 391\u2013408 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03415-6","journal-title":"Endocrine"},{"issue":"2","key":"4795_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12020-021-02770-6","volume":"73","author":"AK Murugan","year":"2021","unstructured":"A.K. Murugan, A.S. Alzahrani, SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves\u2019 disease. Endocrine. 73(2), 243\u2013254 (2021). https:\/\/doi.org\/10.1007\/s12020-021-02770-6","journal-title":"Endocrine"},{"key":"4795_CR6","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.2147\/JIR.S332705","volume":"14","author":"AK Murugan","year":"2021","unstructured":"A.K. Murugan, A.S. Alzahrani, SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases. J. Inflamm. Res. 14, 6191\u20136221 (2021). https:\/\/doi.org\/10.2147\/JIR.S332705","journal-title":"J. Inflamm. Res."},{"issue":"27","key":"4795_CR7","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"F.P. Polack, S.J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J.L. Perez, G. P\u00e9rez Marc, E.D. Moreira, C. Zerbini, R. Bailey, K.A. Swanson, S. Roychoudhury, K. Koury, P. Li, W.V. Kalina, D. Cooper, R.W. Frenck, L.L. Hammitt, W.C. Gruber, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383(27), 2603\u20132615 (2020). https:\/\/doi.org\/10.1056\/NEJMoa2034577","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"4795_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3390\/idr14020034","volume":"14","author":"A Rahmani","year":"2022","unstructured":"A. Rahmani et al., COVID-19 vaccines and their effectiveness: A review. Infect. Disease Rep. 14(2), 310\u2013325 (2022). https:\/\/doi.org\/10.3390\/idr14020034","journal-title":"Infect. Disease Rep."},{"issue":"4","key":"4795_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/imm.13443","volume":"165","author":"Y Chen","year":"2021","unstructured":"Y. Chen, Z. Xu, P. Wang, X.M. Li, Z.W. Shuai, D.Q. Ye, H.F. Pan, New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 165(4), 386\u2013401 (2021). https:\/\/doi.org\/10.1111\/imm.13443","journal-title":"Immunology"},{"issue":"9","key":"4795_CR10","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","volume":"42","author":"K Faksova","year":"2024","unstructured":"K. Faksova, D. Walsh, Y. Jiang, J. Griffin, A. Phillips, A. Gentile, J.C. Kwong, K. Macartney, M. Naus, Z. Grange, S. Escolano, G. Sepulveda, A. Shetty, A. Pillsbury, C. Sullivan, Z. Naveed, N.Z. Janjua, N. Giglio, J. Per\u00e4l\u00e4, S. Nasreen, H. Gidding, P. Hovi, T. Vo, F. Cui, L. Deng, L. Cullen, M. Artama, H. Lu, H.J. Clothier, K. Batty, J. Paynter, H. Petousis-Harris, J. Buttery, S. Black, A. Hviid, COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 42(9), 2200\u20132211 (2024). https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.100","journal-title":"Vaccine"},{"key":"4795_CR11","doi-asserted-by":"publisher","first-page":"1699210","DOI":"10.3389\/fimmu.2025.1699210","volume":"16","author":"AK Murugan","year":"2025","unstructured":"A.K. Murugan, A.S. Alzahrani, COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves\u2019 disease. Front. Immunol. 16, 1699210 (2025). https:\/\/doi.org\/10.3389\/fimmu.2025.1699210","journal-title":"Front. Immunol."},{"issue":"16","key":"4795_CR12","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"T.J. Smith, L. Heged\u00fcs, Graves\u2019 disease. N. Engl. J. Med. 375(16), 1552\u20131565 (2016). https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"4795_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"R.S. Bahn, P.R. Graves, T.J. Smith, Graves\u2019 ophthalmopathy. N. Engl. J. Med. 362(8), 726\u2013738 (2010). https:\/\/doi.org\/10.1056\/NEJMra0905750","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"4795_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1210\/er.2012-1074","volume":"34","author":"WM Wiersinga","year":"2013","unstructured":"W.M. Wiersinga, G.J. Kahaly, A.P. Weetman, L. Bartalena, S.H.S. Pearce, Graves\u2019 orbitopathy: Epidemiology, pathogenesis, and natural history. Endocr. Rev. 34(6), 762\u2013790 (2013). https:\/\/doi.org\/10.1210\/er.2012-1074","journal-title":"Endocr. Rev."},{"issue":"3","key":"4795_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/EJE-07-0666","volume":"158","author":"L Bartalena","year":"2008","unstructured":"L. Bartalena, L. Baldeschi, A. Dickinson, A. Eckstein, P. Kendall-Taylor, C. Marcocci, M. Mourits, P. Perros, K. Boboridis, A. Boschi, N. Curro, C. Daumerie, G. Kahaly, G. Krassas, C. Lane, J. Lazarus, M. Marino, M. Nardi, C. Neoh, W.M. Wiersinga, Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 158(3), 273\u2013285 (2008). https:\/\/doi.org\/10.1530\/EJE-07-0666","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"4795_CR16","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/thy.2010.1634","volume":"20","author":"MN Stan","year":"2010","unstructured":"M.N. Stan, R.S. Bahn, Risk factors for development or deterioration of Graves\u2019 ophthalmopathy. Thyroid. 20(7), 777\u2013783 (2010). https:\/\/doi.org\/10.1089\/thy.2010.1634","journal-title":"Thyroid"},{"issue":"1","key":"4795_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/vaccines14010037","volume":"14","author":"A Abreu Lomba","year":"2026","unstructured":"A. Abreu Lomba, M.E. Tello-Cajiao, M. Morales, A. Mart\u00ednez, M.A. Salazar Moreno, D.A. Vernaza Trujillo, A. Gaibor-Pazmi\u00f1o, J.S. Izquierdo-Condoy, Thyroid Eye Disease Following SARS-CoV-2 Vaccination: Experience of a Case Series. Vaccines. 14(1), 37 (2026). https:\/\/doi.org\/10.3390\/vaccines14010037","journal-title":"Vaccines"},{"key":"4795_CR18","unstructured":"Shah SS, Stokkermans TJ, Patel BC. Thyroid Eye Disease. StatPearls [Internet] 2025. StatPearls Publishing. Treasure Island (FL)."},{"issue":"1","key":"4795_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13643-020-01459-7","volume":"9","author":"J Mu\u00f1oz-Ortiz","year":"2020","unstructured":"J. Mu\u00f1oz-Ortiz, M.C. Sierra-Cote, E. Zapata-Bravo, L. Valenzuela-Vallejo, M.A. Marin-Noriega, P. Uribe-Reina, J.P. Terreros-Dorado, M. G\u00f3mez-Suarez, K. Arteaga-Rivera, A. de-la-Torre, Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature. Syst. Rev. 9(1), 201 (2020).","journal-title":"Syst. Rev."},{"key":"4795_CR20","first-page":"477","volume":"92","author":"GB Bartley","year":"1994","unstructured":"G.B. Bartley, The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota. Trans. Am. Ophthalmol. Soc. 92, 477\u2013588 (1994)","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"10","key":"4795_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/BF03348935","volume":"16","author":"MF Prummel","year":"1993","unstructured":"M.F. Prummel, W.M. Wiersinga, Smoking a risk factor for hypothyroidism [correction of hyperthyroidism]. J. Endocrinol. Invest. 16(10), 827 (1993)","journal-title":"J. Endocrinol. Invest."},{"issue":"7","key":"4795_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/thy.2010.1634","volume":"20","author":"MN Stan","year":"2010","unstructured":"M.N. Stan, R.S. Bahn, Risk factors for development or deterioration of Graves\u2019 ophthalmopathy. Thyroid. 20(7), 777\u2013783 (2010)","journal-title":"Thyroid"},{"issue":"8","key":"4795_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2174\/138920211798120844","volume":"12","author":"O Khalilzadeh","year":"2011","unstructured":"O. Khalilzadeh, S. Noshad, A. Rashidi, A. Amirzargar, Graves\u2019 ophthalmopathy: a review of immunogenetics. Curr. Genomics. 12(8), 564\u2013575 (2011)","journal-title":"Curr. Genomics"},{"issue":"7","key":"4795_CR24","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1167\/iovs.15-18797","volume":"57","author":"JJ Khong","year":"2016","unstructured":"J.J. Khong, K.P. Burdon, Y. Lu, L. Leonardos, K.J. Laurie, J.P. Walsh, A.D. Gajdatsy, P.R. Ebeling, A.A. McNab, T.G. Hardy, R.J. Stawell, G.J. Davis, D. Selva, A. Tsirbas, G.W. Montgomery, S. Macgregor, J.E. Craig, Association of Polymorphisms in MACRO Domain Containing 2 With Thyroid-Associated Orbitopathy. Invest. Ophthalmol. Vis. Sci. 57(7), 3129\u20133137 (2016). https:\/\/doi.org\/10.1167\/iovs.15-18797","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"4795_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/jhg.2016.135","volume":"62","author":"A Ku\u015b","year":"2017","unstructured":"A. Ku\u015b, K. Szyma\u0144ski, B. Jurecka-Lubieniecka, E. Pawlak-Adamska, D. Kula, P. Mi\u015bkiewicz, M. Bolanowski, R. P\u0142oski, A. Bossowski, J. Daroszewski, B. Jarz\u0105b, T. Bednarczuk, Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves\u2019 ophthalmopathy. J. Hum. Genet. 62(3), 373\u2013377 (2017). https:\/\/doi.org\/10.1038\/jhg.2016.135","journal-title":"J. Hum. Genet."},{"key":"4795_CR26","doi-asserted-by":"publisher","first-page":"145750","DOI":"10.1016\/j.gene.2021.145750","volume":"793","author":"F Zhou","year":"2021","unstructured":"F. Zhou, Z. Liang, X. Wang, G. Tan, W. Wei, G. Zheng, X. Ma, D. Tian, H. Li, H. Yu, The VDR gene confers a genetic predisposition to Graves\u2019 disease and Graves\u2019 ophthalmopathy in the Southwest Chinese Han population. Gene. 793, 145750 (2021). https:\/\/doi.org\/10.1016\/j.gene.2021.145750","journal-title":"Gene"},{"issue":"10","key":"4795_CR27","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.11817\/j.issn.1672-7347.2024.240062","volume":"49","author":"M Zhu","year":"2024","unstructured":"M. Zhu, B. Wu, C. Chen-Zhao, H. Chen, W. Xiong, Complement C5\/C5a in the diagnosis and treatment of Graves\u2019 ophthalmopathy: A Mendelian randomized study. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 49(10), 1633\u20131641 (2024). English, Chinese. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2024.240062","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"4795_CR28","doi-asserted-by":"publisher","first-page":"110776","DOI":"10.1016\/j.exer.2025.110776","volume":"263","author":"J Yuan","year":"2026","unstructured":"J. Yuan, L. Meng, Y. Chen, Transcriptome-wide association study identifies key genes in Graves\u2019 ophthalmopathy. Exp. Eye Res. 263, 110776 (2026). https:\/\/doi.org\/10.1016\/j.exer.2025.110776","journal-title":"Exp. Eye Res."},{"issue":"1","key":"4795_CR29","doi-asserted-by":"publisher","first-page":"e240133","DOI":"10.1530\/ETJ-24-0133","volume":"14","author":"C Cardo","year":"2025","unstructured":"C. Cardo, R. Bernardo Santos, A.B. Pinotti Pedro Miklos, S. Barbosa Jaconis, J.H. Romaldini, D. Villagelin, The relationship between cholesterol levels and thyroid eye disease. Eur. Thyroid J. 14(1), e240133 (2025). https:\/\/doi.org\/10.1530\/ETJ-24-0133","journal-title":"Eur. Thyroid J."},{"issue":"5","key":"4795_CR30","doi-asserted-by":"publisher","first-page":"103534","DOI":"10.1016\/j.autrev.2024.103534","volume":"23","author":"F Buonfiglio","year":"2024","unstructured":"F. Buonfiglio, K.A. Ponto, N. Pfeiffer, G.J. Kahaly, A. Gericke, Redox mechanisms in autoimmune thyroid eye disease. Autoimmun. Rev. 23(5), 103534 (2024). https:\/\/doi.org\/10.1016\/j.autrev.2024.103534","journal-title":"Autoimmun. Rev."},{"key":"4795_CR31","doi-asserted-by":"publisher","first-page":"698470","DOI":"10.1155\/2015\/698470","volume":"2015","author":"JR Wall","year":"2015","unstructured":"J.R. Wall, H. Lahooti, E.J. Hibbert, B. Champion, Relationship between Clinical and Immunological Features of Thyroid Autoimmunity and Ophthalmopathy during Pregnancy. J. Thyroid Res. 2015, 698470 (2015)","journal-title":"J. Thyroid Res."},{"issue":"4","key":"4795_CR32","first-page":"293","volume":"128","author":"N Sonino","year":"1993","unstructured":"N. Sonino, M.E. Girelli, M. Boscaro, F. Fallo, B. Busnardo, G.A. Fava, Life events in the pathogenesis of Graves\u2019 disease. A controlled study. Acta Endocrinol. (Copenh). 128(4), 293\u2013296 (1993)","journal-title":"Acta Endocrinol. (Copenh)"},{"issue":"2","key":"4795_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1056\/NEJM199801083380201","volume":"338","author":"L Bartalena","year":"1998","unstructured":"L. Bartalena, C. Marcocci, F. Bogazzi, L. Manetti, M.L. Tanda, E. Dell\u2019Unto, G. Bruno-Bossio, M. Nardi, M.P. Bartolomei, A. Lepri, G. Rossi, E. Martino, A. Pinchera, Relation between therapy for hyperthyroidism and the course of Graves\u2019 ophthalmopathy. N Engl. J. Med. 338(2), 73\u201378 (1998)","journal-title":"N Engl. J. Med."},{"issue":"4","key":"4795_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"P Perros","year":"1993","unstructured":"P. Perros, A.L. Crombie, J.N. Matthews, P. Kendall-Taylor, Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin. Endocrinol. (Oxf). 38(4), 367\u2013372 (1993)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"2","key":"4795_CR35","doi-asserted-by":"publisher","first-page":"183e1","DOI":"10.1016\/j.amjmed.2009.06.030","volume":"123","author":"K Boelaert","year":"2010","unstructured":"K. Boelaert, P.R. Newby, M.J. Simmonds, R.L. Holder, J.D. Carr-Smith, J.M. Heward, N. Manji, A. Allahabadia, M. Armitage, K.V. Chatterjee, J.H. Lazarus, S.H. Pearce, B. Vaidya, S.C. Gough, J.A. Franklyn, Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am. J. Med. 123(2), 183e1\u2013183e9 (2010)","journal-title":"Am. J. Med."},{"issue":"1","key":"4795_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000479629","volume":"7","author":"E Sabini","year":"2018","unstructured":"E. Sabini, I. Ionni, R. Rocchi, P. Vitti, C. Marcocci, M. Marin\u00f2, Occurrence of Graves\u2019 Orbitopathy and Graves\u2019 Hyperthyroidism after a Trauma to the Eye. Eur. Thyroid J. 7(1), 51\u201354 (2018). https:\/\/doi.org\/10.1159\/000479629","journal-title":"Eur. Thyroid J."},{"issue":"9","key":"4795_CR37","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s40618-021-01576-7","volume":"44","author":"G Lanzolla","year":"2021","unstructured":"G. Lanzolla, C. Marcocci, M. Marin\u00f2, Graves\u2019 disease and Graves\u2019 orbitopathy following COVID-19. J. Endocrinol. Invest. 44(9), 2011\u20132012 (2021). https:\/\/doi.org\/10.1007\/s40618-021-01576-7","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"4795_CR38","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaophthalmol.2025.0847","volume":"143","author":"I Garg","year":"2025","unstructured":"I. Garg, B.I. Meyer, R.A. Gallo, S.T. Wester, D. Pelaez, Human Papillomavirus and Thyroid Eye Disease. JAMA Ophthalmol. 143(6), 524\u2013528 (2025). https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.0847","journal-title":"JAMA Ophthalmol."},{"key":"4795_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.11604\/pamj.2025.51.71.47807","volume":"51","author":"S Mekni","year":"2025","unstructured":"S. Mekni, H. Khiari, M. Mekni, J. Sayadi, S. Essayeh, R. Laamouri, I. Rojbi, I.B. Nacef, Thyroid-associated orbitopathy following COVID-19: a case report. Pan Afr. Med. J. 51, 71 (2025). https:\/\/doi.org\/10.11604\/pamj.2025.51.71.47807","journal-title":"Pan Afr. Med. J."},{"issue":"12","key":"4795_CR40","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/life12122084","volume":"12","author":"R Rashad","year":"2022","unstructured":"R. Rashad, R. Pinto, E. Li, M. Sohrab, A.G. Distefano, Thyroid Eye Disease. Life (Basel). 12(12):2084 (2022). https:\/\/doi.org\/10.3390\/life12122084","journal-title":"Life (Basel)"},{"issue":"1","key":"4795_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40618-021-01632-2","volume":"45","author":"T Diana","year":"2021","unstructured":"T. Diana, K.A. Ponto, G.J. Kahaly, Thyrotropin receptor antibodies and Graves\u2019 orbitopathy. J Endocrinol Invest. 2021;44(4):703\u2013712. . Epub 2020 Aug 4. Erratum in: J Endocrinol Invest. 45(1):233 (2022) https:\/\/doi.org\/10.1007\/s40618-021-01632-2","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"4795_CR42","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1167\/iovs.13-12741","volume":"54","author":"AE Kuriyan","year":"2013","unstructured":"A.E. Kuriyan, C.F. Woeller, C.W. O\u2019Loughlin, R.P. Phipps, S.E. Feldon, Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype. Invest. Ophthalmol. Vis. Sci. 54(12), 7370\u20137377 (2013). https:\/\/doi.org\/10.1167\/iovs.13-12741","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"4795_CR43","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1210\/jc.2016-1315","volume":"101","author":"CC Krieger","year":"2016","unstructured":"C.C. Krieger, R.F. Place, C. Bevilacqua, B. Marcus-Samuels, B.S. Abel, M.C. Skarulis, G.J. Kahaly, S. Neumann, M.C. Gershengorn, TSH\/IGF-1 Receptor Cross Talk in Graves\u2019 Ophthalmopathy Pathogenesis. J. Clin. Endocrinol. Metab. 101(6), 2340\u20132347 (2016). https:\/\/doi.org\/10.1210\/jc.2016-1315","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"4795_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICU.0b013e3283499446","volume":"22","author":"RS Douglas","year":"2011","unstructured":"R.S. Douglas, S. Gupta, The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr. Opin. Ophthalmol. 22(5), 385\u2013390 (2011). https:\/\/doi.org\/10.1097\/ICU.0b013e3283499446","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"2","key":"4795_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41433-019-0731-5","volume":"34","author":"M Ludgate","year":"2020","unstructured":"M. Ludgate, Fibrosis in dysthyroid eye disease. Eye (Lond). 34(2), 279\u2013284 (2020). https:\/\/doi.org\/10.1038\/s41433-019-0731-5","journal-title":"Eye (Lond)"},{"issue":"9","key":"4795_CR46","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1210\/clinem\/dgae876","volume":"110","author":"B Yu","year":"2025","unstructured":"B. Yu, Y. Wang, J. Jin, J. Liu, Y. Huang, Y. Wang, C. Zhu, Y. Li, B. Li, J. Sun, D. Li, S. Fang, H. Zhou, CD34\u2009+\u2009Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p. J. Clin. Endocrinol. Metab. 110(9), 2631\u20132644 (2025). https:\/\/doi.org\/10.1210\/clinem\/dgae876","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl1","key":"4795_CR47","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1210\/clinem\/dgac045","volume":"107","author":"L Girnita","year":"2022","unstructured":"L. Girnita, T.J. Smith, J.A.M.J.L. Janssen, It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease. J. Clin. Endocrinol. Metab. 107(Suppl1), S1\u2013S12 (2022). https:\/\/doi.org\/10.1210\/clinem\/dgac045","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"4795_CR48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/bjophthalmol-2020-318330","volume":"106","author":"R Verma","year":"2022","unstructured":"R. Verma, D. Choi, A.J. Chen, C.A. Harrington, D.J. Wilson, H.E. Grossniklaus, R.A. Dailey, J. Ng, E.A. Steele, S.R. Planck, B.S. Korn, D. Kikkawa, C.N. Czyz, J.A. Foster, M. Kazim, G.J. Harris, D.P. Edward, H. Al-Hussain, A.M.Y. Maktabi, C. Alabiad, A. Garcia, J.T. Rosenbaum, Enrichment of IGF-1R and PPAR\u03b3 signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis. Br. J. Ophthalmol. 106(7), 1012\u20131017 (2022). https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318330","journal-title":"Br. J. Ophthalmol."},{"key":"4795_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.10.022","volume":"59","author":"AK Murugan","year":"2019","unstructured":"A.K. Murugan, Special issue: PI3K\/Akt signaling in human cancer. Semin Cancer Biol. 59, 1\u20132 (2019). https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.022","journal-title":"Semin Cancer Biol."},{"key":"4795_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","volume":"59","author":"AK Murugan","year":"2019","unstructured":"A.K. Murugan, mTOR, Role in cancer, metastasis and drug resistance. Semin Cancer Biol. 59, 92\u2013111 (2019). https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.003","journal-title":"Semin Cancer Biol."},{"key":"4795_CR51","doi-asserted-by":"publisher","first-page":"1681875","DOI":"10.3389\/fcell.2025.1681875","volume":"13","author":"C Fang","year":"2025","unstructured":"C. Fang, Z. Zeng, B. Ni, X. Wen, Z. Fang, J. Zou, G. Zhang, Fibroblast PI3K\/AKT signaling and extracellular matrix homeostasis: mechanisms, targets, and delivery challenges. Front. Cell. Dev. Biol. 13, 1681875 (2025). https:\/\/doi.org\/10.3389\/fcell.2025.1681875","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"4795_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/cells5010012","volume":"5","author":"F Christian","year":"2016","unstructured":"F. Christian, E.L. Smith, R.J. Carmody, The Regulation of NF-\u03baB Subunits by Phosphorylation. Cells. 5(1), 12 (2016). https:\/\/doi.org\/10.3390\/cells5010012","journal-title":"Cells"},{"issue":"9","key":"4795_CR53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1167\/iovs.66.9.68","volume":"66","author":"R Liu","year":"2025","unstructured":"R. Liu, X. Xin, S. Ma, J. Guo, C. Wu, X. Qi, B. Luo, Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK\/STAT Signaling Pathway. Invest. Ophthalmol. Vis. Sci. 66(9), 68 (2025). https:\/\/doi.org\/10.1167\/iovs.66.9.68","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"4795_CR54","doi-asserted-by":"publisher","first-page":"205427042413042","DOI":"10.1177\/20542704241304220","volume":"16","author":"A Mukunda","year":"2025","unstructured":"A. Mukunda, J. James, R. Jacob, G.I. Varughese, A.U. Nayak, De novo thyroid eye disease following COVID vaccination several years after radioiodine therapy. JRSM Open. 16(1), 20542704241304220 (2025). https:\/\/doi.org\/10.1177\/20542704241304220","journal-title":"JRSM Open."},{"issue":"2","key":"4795_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ando.2023.10.004","volume":"85","author":"P Caron","year":"2024","unstructured":"P. Caron, P. Imbert, C. Dekeister, S. Grunenwald, Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves\u2019 disease. Ann. Endocrinol. (Paris). 85(2), 100\u2013103 (2024). https:\/\/doi.org\/10.1016\/j.ando.2023.10.004","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"10","key":"4795_CR56","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/vaccines11101574","volume":"11","author":"AK Armeni","year":"2023","unstructured":"A.K. Armeni, G. Markantes, A. Stathopoulou, K. Saltiki, P. Zampakis, S.F. Assimakopoulos, M.A. Michalaki, Thyroid Eye Disease as Initial Manifestation of Graves\u2019 Disease Following Viral Vector SARS-CoV-2 Vaccine: Report of a Case and Review of the Literature. Vaccines. 11(10), 1574 (2023). https:\/\/doi.org\/10.3390\/vaccines11101574","journal-title":"Vaccines"},{"issue":"4","key":"4795_CR57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1210\/clinem\/dgac606","volume":"108","author":"A Mohamed","year":"2023","unstructured":"A. Mohamed, P. Tzoulis, A.L. Kossler, C. Dosiou, New Onset or Deterioration of Thyroid Eye Disease After mRNA SARS-CoV-2 Vaccines: Report of 2 Cases and Literature Review. J. Clin. Endocrinol. Metab. 108(4), 979\u2013985 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgac606","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4795_CR58","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40618-022-01955-8","volume":"46","author":"J Abeillon-du Payrat","year":"2023","unstructured":"J. Abeillon-du Payrat, S. Grunenwald, E. Gall, M. Ladsous, I. Raingeard, P. Caron, Graves\u2019 orbitopathy post-SARS-CoV-2 vaccines: report on six patients. J. Endocrinol. Invest. 46(3), 617\u2013627 (2023). https:\/\/doi.org\/10.1007\/s40618-022-01955-8","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"4795_CR59","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1080\/09273948.2023.2176889","volume":"31","author":"CW Hung","year":"2023","unstructured":"C.W. Hung, C.H. Hung, Reactivation of Graves\u2019 Disease and Thyroid Eye Disease following COVID-19 Vaccination - A Case Report. Ocul Immunol. Inflamm. 31(6), 1286\u20131290 (2023). https:\/\/doi.org\/10.1080\/09273948.2023.2176889","journal-title":"Ocul Immunol. Inflamm."},{"issue":"1","key":"4795_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.15605\/jafes.038.01.19","volume":"38","author":"JH Im Teoh","year":"2023","unstructured":"J.H. Im Teoh, N. Mustafa, N. Wahab, New-onset Thyroid Eye Disease after COVID-19 Vaccination in a Radioactive Iodine-Treated Graves\u2019 Disease Patient: A Case Report and Literature Review. J. ASEAN Fed. Endocr. Soc. 38(1), 125\u2013130 (2023). https:\/\/doi.org\/10.15605\/jafes.038.01.19","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"issue":"2","key":"4795_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/qjmed\/hcac265","volume":"116","author":"H Fujita","year":"2023","unstructured":"H. Fujita, S. Makino, T. Hasegawa, Y. Saima, Y. Tanaka, S. Nagashima, A. Kakehashi, T. Kaburaki, Thyroid eye disease following administration of the BNT162B2 COVID-19 vaccine. QJM. 116(2), 130\u2013132 (2023). https:\/\/doi.org\/10.1093\/qjmed\/hcac265","journal-title":"QJM"},{"key":"4795_CR62","doi-asserted-by":"publisher","first-page":"102809","DOI":"10.1016\/j.jaut.2022.102809","volume":"128","author":"H Bostan","year":"2022","unstructured":"H. Bostan, B. Ucan, M. Kizilgul, M. Calapkulu, S. Hepsen, U. Gul, I. Ozturk Unsal, E. Cakal, Relapsed and newly diagnosed Graves\u2019 disease due to immunization against COVID-19: A case series and review of the literature. J. Autoimmun. 128, 102809 (2022). https:\/\/doi.org\/10.1016\/j.jaut.2022.102809","journal-title":"J. Autoimmun."},{"key":"4795_CR63","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.ajoc.2022.101484","volume":"26","author":"OT Cheng","year":"2022","unstructured":"O.T. Cheng, D.M. Schlachter, Teprotumumab in advanced reactivated thyroid eye disease. Am. J. Ophthalmol. Case Rep. 26, 101484 (2022). https:\/\/doi.org\/10.1016\/j.ajoc.2022.101484","journal-title":"Am. J. Ophthalmol. Case Rep."},{"issue":"7","key":"4795_CR64","doi-asserted-by":"publisher","first-page":"103096","DOI":"10.1016\/j.autrev.2022.103096","volume":"21","author":"A Patrizio","year":"2022","unstructured":"A. Patrizio, S.M. Ferrari, A. Antonelli, P. Fallahi, Worsening of Graves\u2019 ophthalmopathy after SARS-CoV-2 mRNA vaccination. Autoimmun. Rev. 21(7), 103096 (2022). https:\/\/doi.org\/10.1016\/j.autrev.2022.103096","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"4795_CR65","doi-asserted-by":"publisher","first-page":"e05926","DOI":"10.1002\/ccr3.5926","volume":"10","author":"S Grunenwald","year":"2022","unstructured":"S. Grunenwald, G. Lethellier, P. Imbert, C. Dekeister, P. Caron, Orbital inflammatory disease following mRNA SARS-CoV-2 vaccine. Clin. Case Rep. 10(6), e05926 (2022). https:\/\/doi.org\/10.1002\/ccr3.5926","journal-title":"Clin. Case Rep."},{"issue":"1","key":"4795_CR66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/tjo.tjo_61_21","volume":"12","author":"KS Park","year":"2022","unstructured":"K.S. Park, S.E. Fung, M. Ting, D.J. Ozzello, J.S. Yoon, C.Y. Liu, B.S. Korn, D.O. Kikkawa, Thyroid eye disease reactivation associated with COVID-19 vaccination. Taiwan. J. Ophthalmol. 12(1), 93\u201396 (2022). https:\/\/doi.org\/10.4103\/tjo.tjo_61_21","journal-title":"Taiwan. J. Ophthalmol."},{"issue":"12","key":"4795_CR67","doi-asserted-by":"publisher","first-page":"e246432","DOI":"10.1136\/bcr-2021-246432","volume":"14","author":"TJ Goblirsch","year":"2021","unstructured":"T.J. Goblirsch, A.E. Paulson, G. Tashko, A.J. Mekonnen, Graves\u2019 disease following administration of second dose of SARS-CoV-2 vaccine. BMJ Case Rep. 14(12), e246432 (2021). https:\/\/doi.org\/10.1136\/bcr-2021-246432","journal-title":"BMJ Case Rep."},{"issue":"9","key":"4795_CR68","doi-asserted-by":"publisher","first-page":"002807","DOI":"10.12890\/2021_002807","volume":"8","author":"G Pierman","year":"2021","unstructured":"G. Pierman, E. Delgrange, C. Jonas, Recurrence of Graves\u2019 Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence? Eur. J. Case Rep. Intern. Med. 8(9), 002807 (2021). https:\/\/doi.org\/10.12890\/2021_002807","journal-title":"Eur. J. Case Rep. Intern. Med."},{"issue":"6","key":"4795_CR69","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1097\/IOP.0000000000002059","volume":"01","author":"TJ Rubinstein","year":"2021","unstructured":"T.J. Rubinstein, Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves\u2019 Disease: A Case Report. Ophthalmic Plast. Reconstr. Surg. 01;37(6):e221\u2013e223 (2021) https:\/\/doi.org\/10.1097\/IOP.0000000000002059","journal-title":"Ophthalmic Plast. Reconstr. Surg. 2021 Nov-Dec"},{"issue":"7","key":"4795_CR70","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","volume":"28","author":"IP Trougakos","year":"2022","unstructured":"I.P. Trougakos, E. Terpos, H. Alexopoulos, M. Politou, D. Paraskevis, A. Scorilas, E. Kastritis, E. Andreakos, M.A. Dimopoulos, Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol. Med. 28(7), 542\u2013554 (2022). https:\/\/doi.org\/10.1016\/j.molmed.2022.04.007","journal-title":"Trends Mol. Med."},{"issue":"6","key":"4795_CR71","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/v3060920","volume":"3","author":"MR Thompson","year":"2011","unstructured":"M.R. Thompson, J.J. Kaminski, E.A. Kurt-Jones, K.A. Fitzgerald, Pattern recognition receptors and the innate immune response to viral infection. Viruses. 3(6), 920\u2013940 (2011). https:\/\/doi.org\/10.3390\/v3060920","journal-title":"Viruses"},{"issue":"11","key":"4795_CR72","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"K.L. Rock, E. Reits, J. Neefjes, Present Yourself! By MHC Class I and MHC Class II Molecules. Trends Immunol. 37(11), 724\u2013737 (2016). https:\/\/doi.org\/10.1016\/j.it.2016.08.010","journal-title":"Trends Immunol."},{"issue":"3","key":"4795_CR73","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3390\/pathophysiology29030039","volume":"29","author":"LP Churilov","year":"2022","unstructured":"L.P. Churilov, M.G. Normatov, V.J. Utekhin, Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19. Endocr. Autoimmunity? Pathophysiology. 29(3), 486\u2013494 (2022). https:\/\/doi.org\/10.3390\/pathophysiology29030039","journal-title":"Endocr. Autoimmunity? Pathophysiology"},{"key":"4795_CR74","doi-asserted-by":"publisher","first-page":"108480","DOI":"10.1016\/j.clim.2020.108480","volume":"217","author":"A Vojdani","year":"2020","unstructured":"A. Vojdani, D. Kharrazian, Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin. Immunol. 217, 108480 (2020). https:\/\/doi.org\/10.1016\/j.clim.2020.108480","journal-title":"Clin. Immunol."},{"issue":"9","key":"4795_CR75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","volume":"8","author":"I Muller","year":"2020","unstructured":"I. Muller, D. Cannavaro, D. Dazzi, D. Covelli, G. Mantovani, A. Muscatello, E. Ferrante, E. Orsi, V. Resi, V. Longari, M. Cuzzocrea, A. Bandera, E. Lazzaroni, A. Dolci, F. Ceriotti, T.E. Re, A. Gori, M. Arosio, M. Salvi, SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 8(9), 739\u2013741 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30266-7","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"4795_CR76","doi-asserted-by":"publisher","first-page":"101743","DOI":"10.1016\/j.beem.2023.101743","volume":"37","author":"Y Wang","year":"2023","unstructured":"Y. Wang, S. Fang, H. Zhou, Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms. Best Pract. Res. Clin. Endocrinol. Metab. 37(2), 101743 (2023). https:\/\/doi.org\/10.1016\/j.beem.2023.101743","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"4795_CR77","doi-asserted-by":"publisher","first-page":"1544436","DOI":"10.3389\/fopht.2025.1544436","volume":"5","author":"J Murdock","year":"2025","unstructured":"J. Murdock, J. Nguyen, B.J. Hurtgen, C. Andorfer, J. Walsh, A. Lin, C. Tubbs, K. Erickson, K. Cockerham, The role of IL-6 in thyroid eye disease: an update on emerging treatments. Front. Ophthalmol. (Lausanne). 5, 1544436 (2025). https:\/\/doi.org\/10.3389\/fopht.2025.1544436","journal-title":"Front. Ophthalmol. (Lausanne)"},{"key":"4795_CR78","doi-asserted-by":"publisher","first-page":"1392956","DOI":"10.3389\/fimmu.2024.1392956","volume":"15","author":"X Shu","year":"2024","unstructured":"X. Shu, Y. Shao, Y. Chen, C. Zeng, X. Huang, R. Wei, Immune checkpoints: new insights into the pathogenesis of thyroid eye disease. Front. Immunol. 15, 1392956 (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1392956","journal-title":"Front. Immunol."},{"issue":"12","key":"4795_CR79","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1055\/a-0723-9023","volume":"50","author":"T Diana","year":"2018","unstructured":"T. Diana, P.D. Olivo, G.J. Kahaly, Thyrotropin Receptor Blocking Antibodies. Horm. Metab. Res. 50(12), 853\u2013862 (2018). https:\/\/doi.org\/10.1055\/a-0723-9023","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"4795_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2012.0374","volume":"23","author":"SM McLachlan","year":"2013","unstructured":"S.M. McLachlan, B. Rapoport, Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. Thyroid. 23(1), 14\u201324 (2013). https:\/\/doi.org\/10.1089\/thy.2012.0374","journal-title":"Thyroid"},{"issue":"3","key":"4795_CR81","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.beem.2011.10.003","volume":"26","author":"S Iyer","year":"2012","unstructured":"S. Iyer, R. Bahn, Immunopathogenesis of Graves\u2019 ophthalmopathy: the role of the TSH receptor. Best Pract. Res. Clin. Endocrinol. Metab. 26(3), 281\u2013289 (2012). https:\/\/doi.org\/10.1016\/j.beem.2011.10.003","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"4795_CR82","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s13167-026-00435-w","volume":"17","author":"H Zhang","year":"2026","unstructured":"H. Zhang, L. Yang, R. Li, R. Bahn, H. Guan, H. Zhou, The predictive, preventive, and personalised medicine of thyroid eye disease: a comprehensive guide to risk minimization. EPMA J. 17(2), 351\u2013372 (2026). https:\/\/doi.org\/10.1007\/s13167-026-00435-w","journal-title":"EPMA J."},{"key":"4795_CR83","doi-asserted-by":"publisher","first-page":"102898","DOI":"10.1016\/j.jaut.2022.102898","volume":"132","author":"Y Rodr\u00edguez","year":"2022","unstructured":"Y. Rodr\u00edguez, M. Rojas, S. Beltr\u00e1n, F. Polo, L. Camacho-Dom\u00ednguez, S.D. Morales, M.E. Gershwin, J.M. Anaya, Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J. Autoimmun. 132, 102898 (2022). https:\/\/doi.org\/10.1016\/j.jaut.2022.102898","journal-title":"J. Autoimmun."},{"key":"4795_CR84","doi-asserted-by":"publisher","first-page":"919979","DOI":"10.3389\/fimmu.2022.919979","volume":"13","author":"Y Xie","year":"2022","unstructured":"Y. Xie, Y. Liu, Y. Liu, The Flare of Rheumatic Disease After SARS-CoV-2 Vaccination: A Review. Front. Immunol. 13, 919979 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.919979","journal-title":"Front. Immunol."},{"key":"4795_CR85","doi-asserted-by":"publisher","first-page":"899526","DOI":"10.3389\/fimmu.2022.899526","volume":"13","author":"G Sprow","year":"2022","unstructured":"G. Sprow, M. Afarideh, J. Dan, R. Feng, E. Keyes, M. Grinnell, J. Concha, V.P. Werth, Autoimmune Skin Disease Exacerbations Following COVID-19 Vaccination. Front. Immunol. 13, 899526 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.899526","journal-title":"Front. Immunol."},{"issue":"7","key":"4795_CR86","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00296-023-05283-9","volume":"43","author":"K Kouranloo","year":"2023","unstructured":"K. Kouranloo, M. Dey, H. Elwell, A. Nune, A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19. Rheumatol. Int. 43(7), 1221\u20131243 (2023). https:\/\/doi.org\/10.1007\/s00296-023-05283-9","journal-title":"Rheumatol. Int."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04795-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04795-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:02:10Z","timestamp":1790593330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04795-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4795"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04795-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved (RAC-2210025) by the Institutional Review Board (IRB) of King Faisal Specialist Hospital and Research Centre (KFSH & RC), Riyadh, Saudi Arabia.","order":1,"name":"Ethics","label":"Institutional review board (IRB)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"320"}}